Objective Metabolic syndrome consists of a collection of cardiovascular risk factors and is considered to increase the risk of cardiovascular morbidity and mortality. This study aimed to investigate whether altered baroreflex sensitivity (BRS), a measure of cardiovascular autonomic control, is related to metabolic syndrome and insulin resistance.
Introduction
Metabolic syndrome was described as early as in 1923 by Kylin but was not rediscovered until 1988, when Reaven presented what he called syndrome X [1, 2] . It was described as a clustering of several cardiovascular risk factors including hypertension, glucose intolerance, dyslipidemia and insulin resistance [2] . Since then the syndrome has been further described by several investigators. The World Health Organization proposed a standardized definition in 1998 [3] , but more recently the National Cholesterol Education Program (NCEP) expert panel provided a new definition, the Adult Treatment Panel III (ATP III) [4] , which is more easily used in the clinical setting.
Several different studies have demonstrated that patients with metabolic syndrome have an increased risk of cardiovascular morbidity and mortality [5] [6] [7] [8] [9] [10] . The epidemic increases in obesity and sedentary lifestyle have resulted in an increased prevalence of metabolic syndrome, as well as later myocardial infarction and other cardiac events [11] . Insulin resistance has been suggested as a common denominator in metabolic syndrome [2] , but an altered autonomic tone has also been proposed to be of pathogenic importance [12, 13] .
Autonomic balance is often disturbed in different kinds of cardiovascular disease. Several non-invasive measures to assess cardiovascular autonomic balance have been proposed; for example, heart rate variability (HRV), blood pressure variability (BPV) and baroreflex sensitivity (BRS). A decreased BRS has been described in hypertension, heart failure and myocardial infarction [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . A reduced HRV and a raised BPV also seem to be associated with the same disorders [15, [24] [25] [26] [27] .
To our knowledge, no studies have been carried out to evaluate the relationship between BRS and metabolic syndrome (using the NCEP/ATP III definition). The primary aim of this study was to investigate whether BRS, measured by both the sequence method and by frequency domain analysis, is related to the presence of metabolic syndrome and insulin resistance. The study was conducted in elderly subjects participating in the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. The HRV and BPV were also evaluated in the relation to metabolic syndrome and insulin resistance as secondary aims.
Materials
Subjects Subjects eligible for this study were men and women living in the community of Uppsala, Sweden. The subjects were chosen from the community register and were invited in a randomized order. They received an invitation by letter within 2 months following their 70th birthday. The participation rate was 50.1% (i.e. 1016 of 2025 persons invited). The Ethics Committee of the University of Uppsala approved the study and the participants gave their informed consent. The distribution according to sex was 51% women and 49% men.
Healthy reference groups
A group with no cardiovascular diagnosis or major risk factors was identified. The exclusion criteria were: history of any cardiovascular diagnosis or medication, obesity (body mass index > 30 kg/m 2 ), hypertension (antihypertensive treatment or blood pressure > 140/90 mmHg), diabetes (antidiabetic treatment including diet or fasting blood glucose > 6.1 mmol/l), hypercholesterolemia (antihyperlipidemic treatment or low-density lipoproteincholesterol > 4.1 mmol/l) and current smoking. This group was denoted the PIVUS cardiovascular healthy reference group.
To give a descriptive age-reference to this PIVUS cardiovascular healthy reference group, 10 young men and 10 young women (age 20-25 years) with the same exclusion criteria were investigated with an identical protocol. This group was denoted the young cardiovascular healthy reference group.
Subject characteristics and major cardiovascular risk factors are presented in Table 1 .
As the participation rate in this cohort was only 50%, we carried out an evaluation of cardiovascular disorders and medications in 100 consecutive non-participants. The prevalences of cardiovascular drug intake, history of myocardial infarction, coronary revascularization, antihypertensive medication, statin use and insulin treatment were similar to those in the investigated sample, while the prevalences of diabetes, congestive heart failure and stroke tended to be higher among the non-participants (see Table 2 ).
Methods

Basic investigations
Prior to their examination, subjects completed a questionnaire concerning their medical history, regular medication (Table 2 ) and smoking habits. All subjects were investigated in the morning after an overnight fast and no medication was taken on the day of the investigation. Participants were in the supine position in a quiet room at constant temperature.
Recordings of height, weight and abdominal and hip dimensions were performed and blood samples were taken and analysed by standard laboratory techniques.
Recordings of electrocardiogram, blood pressure and breathing A six-precordial-lead electrocardiogram was recorded (Mingocard 7; Siemens Elema, Stockholm, Sweden).
The skin under the electrodes was shaved when necessary and scrubbed in order to minimize electrical resistance. The reference electrode consisted of shortcircuited limb leads and was placed on the manubrium sterni. The blood pressure was recorded via an intraarterial catheter in the brachial artery. Breathing was recorded with a custom-made impedance meter via two pairs of electrodes, placed about 5 cm below each armpit. Spontaneous breathing was allowed during the first 10 min. During the last 5 min, breathing was limited to a rate of 12 breaths/minute (0.2 Hz). Only the 5 min of controlled breathing were used for analysis. The electrocardiogram and blood pressure signals were digitized at a sampling frequency of 500 Hz and the breathing signal at 10 Hz. Artefacts were removed from the electrocardiogram, excluding non-adequate trigs (ectopic beats) and trigging unmarked R-peaks. Subjects with frequent ectopic beats (i.e. more than 10%) were excluded (n ¼ 36), as were those with atrial fibrillation (n ¼ 25). Subjects were also excluded if they had a pacemaker or whenever data were inadequate owing to failure of arterial cannulation (11% of the sample) or technical disturbances. Thus, of the 1016 investigated subjects, data on RR-interval and systolic blood pressure (SBP) variability were present in 782 subjects (77%).
Sequence analysis
A sequence was defined as a series of at least three consecutive heartbeats during which the SBP and the following RR interval either increased or decreased by a minimum of 1 mmHg/beat and 3 ms/beat, respectively. A custom-made software (based on Excel; Microsoft Inc., Seattle, Washington, USA) scanned the data and detected such sequences. Both increasing and decreasing slopes were analysed and the mean value of the regression slopes was used as a measure of BRS.
Spectral analysis
Spectral analysis of SBP and RR-interval variations was performed with software developed (Ekman Biomedical Data AB, Gothenburg, Sweden) using MATLAB (MathWorks Inc., Natick, Massachusetts, USA). The signal was linearly detrended and a low-pass filter (fifth-order Butterworth) was subsequently applied using a cut-off frequency of 1 Hz. The power spectrum density of the signal was determined by using fast Fourier transform, which was carried out using the Welch algorithm. The data were divided into two blocks with a 50% overlap and each block was windowed using the Hamming function. The a index was calculated from the fast Fourier transform analysis as the square root of the power ratio of the RR interval and SBP over 0.15-0.25 Hz [the high frequency (HF) band]. The a index was taken as an index of BRS. The powers of the RR interval and the SBP were also calculated in the low-frequency (LF) band (0.03-0.15 Hz).
Left ventricular hypertrophy
The left ventricular mass was determined by M-mode echocardiography (Acuson XP128; Acuson Mountain View, California, USA) with a 2.5 MHz transducer in the parasternal position using the Penn convention. A left ventricular mass > 100 g/m 2 body surface area for women and > 131 g/m 2 body surface area for men was considered to be left ventricular hypertrophy (LVH).
Definition of metabolic syndrome
Metabolic syndrome was defined according to the NCEP/ ATP III criteria and required three of the following five criteria to be fulfilled [4] : blood pressure > 130/85 mmHg or antihypertensive treatment, fasting blood glucose > 5.6 mmol/l, serum triglycerides > 1.7 mmol/l, abdominal dimension > 102 cm in men and > 88 cm in women, high-density lipoprotein-cholesterol < 1.0 mmol/l in men and < 1.3 mmol/l in women.
Serum insulin was measured by an enzymatic-immunological assay (Boehringer Mannheim, Mannheim, Germany). The homeostatic model assessment (HOMA) insulin resistance index was defined as: fasting blood glucose Â serum insulin / 22.5.
Statistical analysis
StatView (SAS Inc., Cary, North Carolina, USA) was used for statistical analysis. If variables failed to show a normal distribution, a natural logarithmic transformation was carried out. Analysis of variance was used to compare different groups and analysis of covariance was used for correction for heart rate and different medications. Linear regression analysis, univariate and multivariate, was used to explore the correlation between insulin resistance and different variables. Only P values less than 0.05 were accepted as statistically significant.
Results
Basic data on metabolic syndrome
In the present sample 172 fulfilled the criteria for metabolic syndrome. As can be seen in Table 3 , all of the components included in the syndrome definition (blood pressure, serum triglycerides, high-density lipoproteincholesterol, waist circumference and fasting blood glucose) were significantly impaired in those with the syndrome when compared with those without. Metabolic syndrome was more common in females than in males (29 versus 16%, P < 0.0001).
The duration of hypertension was 10.3 AE 9.7 (SD) years (median 7.0 years, range 0.1-42 years). Forty-six per cent of the metabolic syndrome subjects were on regular antihypertensive medication compared with 24% in the group without metabolic syndrome (P < 0.0001). However, no significant differences between the groups were seen regarding the proportions of the different antihypertensive drug classes presented in Table 2 ). LVH at echocardiography was more prevalent among those with metabolic syndrome (37 versus 17% in those without the syndrome, P < 0.0001). Previous myocardial infarction did not, however, significantly differ between the groups (8.0 versus 6.5% in those without the syndrome, P ¼ 0.43).
Metabolic syndrome and BRS
Subjects with metabolic syndrome showed significantly lower values (P < 0.0001) of BRS slopes (both increasing and decreasing slopes) than subjects without metabolic syndrome ( Fig. 1 and Table 4 ). Increasing and decreasing baroreceptor slopes gave similar results and were therefore combined. The difference between the groups remained highly significant after correction for heart rate, myocardial infarction, heart failure, LVH and different cardiovascular medications (b-blockers, calcium channel antagonists, angiotensin-converting enzyme inhibitors, digitalis, other antiarrythmic drugs and diuretics) (P < 0.0001). The difference in BRS between those with and those without metabolic syndrome was seen in both women and in men (P ¼ 0.0006 in women and P ¼ 0.0025 in men).
A significant graded reduction (P < 0.0001) in BRS was seen with an increasing number of components of metabolic syndrome (Fig. 2) . This association was still significant (P < 0.0001) after correction for heart rate, myocardial infarction, heart failure, LVH and different medications (as above).
Further analysis revealed that obesity, hypertension and raised levels of triglycerides were the major factors for a decreased BRS in metabolic syndrome. The separate influence of all five components of metabolic syndrome on BRS is displayed in Table 5 .
Similar to that seen when BRS was evaluated using the sequence method, the BRS calculated as the a index obtained by the fast Fourier transform method in the HF region was significantly lower in subjects with metabolic syndrome than in those without, also after correction for heart rate, myocardial infarction, heart failure, LVH and cardiovascular medications (Table 4 , P < 0.0001).
Of the secondary variables, the RR-interval variability, measured by the standard deviation of the heart rate (SDNN) in the time domain and in the HF and LF bands of the frequency domain, was significantly decreased in subjects with metabolic syndrome (P ¼ 0.0008, P < 0.0001 and P ¼ 0.005, respectively) ( Table 4) . After correction for heart rate, myocardial infarction, heart failure, LVH and cardiovascular medications, these differences showed borderline significance for SDNN (P ¼ 0.052), were significant in the HF band 
Baroreceptor sensitivity
Box plot showing the 10th, 25th, 50th, 75th and 90th percentiles for baroreceptor sensitivity (ms/mmHg) in subjects with and without metabolic syndrome (MetS). P < 0.0001 for the difference between groups.
(P ¼ 0.0081) but were not significant in the LF band (P ¼ 0.19).
The variability of SBP in the HF band was significantly increased in subjects with metabolic syndrome (P < 0.0001) ( Table 4 ), but there was no significant difference in the LF band (P ¼ 0.64). After correction for heart rate, myocardial infarction, heart failure, LVH and cardiovascular medications, the difference in SBP variability in the HF region remained significant (P < 0.0003).
Basically the same results were obtained when men and women were analysed separately (data not shown).
Insulin resistance
The median value for the HOMA insulin resistance index was 1.69 mmol/l mU/l (10th and 90th percentiles, 0.86 and 4.01) in the total sample and was 1.58 (10th and 90th percentiles, 0.83 and 3.39) when diabetics (12% of the sample) were excluded.
BRS evaluated with the sequence method was inversely related to the HOMA insulin resistance index, as shown in Fig. 3 (r ¼ À0.18, P < 0.0001). Similar results were obtained if the diabetics were excluded from the analysis (r ¼ À0.16, P ¼ 0.0001).
The relationship between BRS and the HOMA insulin resistance index was seen in both women (r ¼ À0.19, P ¼ 0.0004) and men (r ¼ À0.12, P ¼ 0.040).
The relationship between BRS and the HOMA insulin resistance index was still significant after correction for heart rate, coronary heart disease, stroke, LVH and all of the cardiovascular drugs presented in Table 2 (r ¼ À0.12,
Similar results were obtained if BRS was evaluated with the a-index method in the HF band (r ¼ À0.21, P ¼ 0.0001 versus the HOMA index).
Of the secondary variables, the RR-interval variability, measured by SDNN in the time domain and in the HF and LF bands of the frequency domain, was inversely related to the HOMA index (r ¼ À0.11, P ¼ 0.0028, r ¼ À0.13, P ¼ 0.0003 and r ¼ À0.08, P ¼ 0.035, respectively). Variability of SBP in the HF band, but not in the LF band, was directly related to the HOMA index (r ¼ À0.13, P ¼ 0.0005 and r ¼ À0.03, P ¼ 0.47, respectively).
Discussion
This study showed that BRS is reduced in subjects with metabolic syndrome and that BRS is impaired in insulin resistance, as reflected by an increased HOMA index. This was seen in an elderly sample with a high prevalence of systolic hypertension. These findings were still present after correction for various confounders (i.e. heart rate, heart failure, history of myocardial infarction, LVH and use of different cardiovascular medications). The fact
Baroreceptor sensitivity and metabolic syndrome Lindgren et al. 147 Table 4 Heart rate, baroreceptor sensitivity (BRS) measured by the a-index method in the high-frequency (HF) and low-frequency (LF) bands, standard deviation of the heart rate (SDNN), RR-interval and systolic blood pressure (SBP) variabilities in the HF and LF regions in subjects with and without metabolic syndrome that the results remained significant after correction for heart rate is of major importance, as Abrahamsson et al. have shown that the heart rate and BRS have an inverse exponential relationship [28] and since the heart rate was significantly higher in subjects with metabolic syndrome in our study.
To our knowledge, no previous studies have been carried out to evaluate the relationship between BRS and metabolic syndrome. However, other studies have considered the components of the syndrome separately. It has been shown that BRS is reduced in hypertension [16, [20] [21] [22] [23] , obesity [29] [30] [31] , dyslipidemia [32] and diabetes [17, 33] . In addition to these studies, a few others have considered two or three of the components together. Takahashi et al.
proposed that hypertension acts synergistically with type 2 diabetes to depress cardiac autonomic function measured as BRS, and that insulin resistance may play a pathogenesis role [34] . BRS was significantly lower in subjects with insulin-resistance syndrome (in this case including hypertension, hypertriglyceridemia and hyperinsulinemia) as compared with healthy subjects [35] . Grassi et al. showed that the association between hypertension and obesity triggers a sympathetic activation and baroreflex impairment that is more extensive than when found in either of these conditions alone [30] .
These cited results support those of our study and indicate that BRS is impaired in the separate components, as well as in metabolic syndrome as a whole. BRS is considered mainly to reflect vagal activity, since it is almost abolished by atropine but mainly not affected by sympathetic blockade [36] . The conclusion of a close association between cardiac vagal activity and metabolic Table 5 Baroreceptor sensitivity (BRS) measured by the slope method, standard deviation of the heart rate (SDNN), RR-interval and systolic blood pressure (SBP) variabilities in the highfrequency band in subjects with or without the five different components included in metabolic syndrome syndrome, derived from the present study, is supported by the results by Lind and André n [37] . They investigated whether the components of metabolic syndrome were related to heart rate recovery after exercise, another measure of vagal activity. According to their study, such relations were present and impairment in vagal activity was also related to a direct measure of insulin resistance. The fact that we showed significantly lower HRV in the HF band in subjects with metabolic syndrome further supports the conclusion that vagal activity is of importance for metabolic syndrome. Our study does not, however, indicate whether the autonomic dysfunction causes metabolic syndrome or whether it is the other way around. This has to be studied in prospective investigations.
BRS was gradually reduced with an increasing number of components of metabolic syndrome, without consideration to which criteria are fulfilled and which are not. This indicates that the number of components is crucial to the extent of BRS impairment and, hence, cardiovascular risk. This finding supports the use of the NCEP/ATP III definition of metabolic syndrome, and also raises the idea that BRS may be an important marker for assessing cardiovascular risk in patients with metabolic syndrome, even though prospective studies are needed to confirm this.
The question of whether any one of the components in metabolic syndrome is more important than others as concerns aetiology is unclear. Insulin resistance along with obesity, due to a high caloric diet and a sedentary lifestyle, are generally accepted as the underlying mechanisms [38] . The importance of obesity is supported by the fact that weight loss improves most of the risk factors associated with metabolic syndrome [11] . According to our results, obesity, hypertension and raised levels of triglycerides are the main factors being associated with a reduced BRS. Of these components, hypertension might be the most important in this sample of elderly subjects as the prevalence of systolic hypertension was very high.
A low BRS was also related to insulin sensitivity, as calculated by the HOMA index [39] . Although insulin resistance is not a criteria included in the NCEP/ATP III definition of metabolic syndrome, most investigators in this field regards insulin sensitivity as a major common link in metabolic syndrome [2] . HRV in the HF region, another marker of cardiovascular vagal activity, was also inversely related to insulin resistance, further emphasizing a potential link between a low vagal activity and insulin resistance.
Analysis of resting supine heart rate and blood pressure variability is not a powerful tool to assess sympathetic nerve activity, but would rather serve as a marker of the balance and interplay between the sympathetic and parasympathetic parts of the autonomous nervous system. Other methods have shown the sympathetic nerve activity to increase with insulin resistance, obesity and metabolic syndrome [40, 41] , and it could therefore be that a part of the reduction in BRS and other secondary variables shown in the present study could also be an effect of the increased sympathetic nerve activity along with a reduction in vagal tone.
We included a healthy young reference group in our study. The size of this young sample was not big enough for any formal statistical comparison, but the values for BRS and the RR-interval variability evaluated in the present study were considerably higher, while the variability of SBP seemed to be lower in this young healthy group compared with the PIVUS healthy reference group.
A limitation to the present study is the low participation rate. However, based on a health questionnaire sent to 100 consecutive non-participants, the major difference between studied subjects and non-participating individuals was a higher incidence of stroke in those unwilling to participate. This should not possibly affect our results, but is still worth mentioning as a possible source of error. Our study was also carried out in elderly Caucasians and therefore must be confirmed in other age and ethnic groups.
In conclusion, our results indicate that cardiovascular autonomic imbalance, measured as a low BRS, is present in metabolic syndrome and in insulin resistance. A reduced BRS might, however, be either the cause of or a consequence of metabolic syndrome. As BRS mainly reflects vagal activity, future prospective studies will address the possibility of vagal impairment in the pathogenesis of metabolic syndrome.
